288 related articles for article (PubMed ID: 9476946)
1. Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction.
Murashima S; Takeda K; Matsumura K; Yamakado K; Sakuma H; Kitano T; Nakagawa T; Ichihara T; Yamakado T; Murata K
J Nucl Med; 1998 Feb; 39(2):334-8. PubMed ID: 9476946
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
[TBL] [Abstract][Full Text] [Related]
3. Prolonged lung retention of iodine-123-MIBG in diabetic patients.
Unlü M; Inanir S
J Nucl Med; 1998 Jan; 39(1):116-8. PubMed ID: 9443749
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
[TBL] [Abstract][Full Text] [Related]
5. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function.
Nagamachi S; Jinnouchi S; Kurose T; Ohnishi T; Flores LG; Nakahara H; Futami S; Tamura S; Matsukura S
Ann Nucl Med; 1998 Dec; 12(6):323-31. PubMed ID: 9972369
[TBL] [Abstract][Full Text] [Related]
6. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function.
Pace L; Betocchi S; Losi MA; Della Morte AM; Ciampi Q; Nugnez R; Chiariello M; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):20-5. PubMed ID: 15195000
[TBL] [Abstract][Full Text] [Related]
7. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.
Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M
J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299
[TBL] [Abstract][Full Text] [Related]
8. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Langer A; Freeman MR; Josse RG; Armstrong PW
J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
[TBL] [Abstract][Full Text] [Related]
9. [Serial change of 123I-metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy].
Yamakado K; Takeda K; Kitano T; Nakagawa T; Futagami Y; Konishi T; Hamada M; Nakano T; Ichihara T
Kaku Igaku; 1990 Jul; 27(7):703-8. PubMed ID: 2232338
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.
Kamiyoshi Y; Yazaki Y; Urushibata K; Koizumu T; Kasai H; Izawa A; Kinoshita O; Hongo M; Ikeda U
Am J Cardiol; 2008 May; 101(10):1482-6. PubMed ID: 18471462
[TBL] [Abstract][Full Text] [Related]
11. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.
Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Nakajima K; Taki J; Mabuchi H
J Nucl Med; 2002 Jan; 43(1):15-20. PubMed ID: 11801697
[TBL] [Abstract][Full Text] [Related]
13. [123I-MIBG myocardial scintigraphy in diabetic patients: association with autonomic neuropathy].
Nagamachi S; Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Watanabe K; Nakatsuru K; Toshimori T; Matsukura S
Kaku Igaku; 1994 Sep; 31(9):1059-69. PubMed ID: 7967189
[TBL] [Abstract][Full Text] [Related]
14. Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats.
Kurata C; Okayama K; Wakabayashi Y; Shouda S; Mikami T; Tawarahara K; Sugiyama T
J Nucl Med; 1997 Nov; 38(11):1677-80. PubMed ID: 9374332
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of cardiac sympathetic innervation with 123I-metaiodobenzylguanidine in patients with diabetes mellitus].
Lumbreras Vega L; Fernández Soto M; Nevado Jiménez A; Becerra García D; Nieto Serrano R; Fernández Fernández B; Escobar Jiménez F; Martínez Sampere JJ
Rev Esp Cardiol; 1998; 51 Suppl 1():60-6. PubMed ID: 9549400
[TBL] [Abstract][Full Text] [Related]
16. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy].
Narita M; Kurihara T
J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
Narita M; Kurihara T
J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
[TBL] [Abstract][Full Text] [Related]
18. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients.
Ohshima S; Isobe S; Izawa H; Nanasato M; Ando A; Yamada A; Yamada K; Kato TS; Obata K; Noda A; Nishizawa T; Kato K; Nagata K; Okumura K; Murohara T; Yokota M
J Am Coll Cardiol; 2005 Dec; 46(11):2061-8. PubMed ID: 16325043
[TBL] [Abstract][Full Text] [Related]
19. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
[TBL] [Abstract][Full Text] [Related]
20. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability.
Murata K; Sumida Y; Murashima S; Matsumura K; Takeda H; Nakagawa T; Shima T
Diabet Med; 1996 Mar; 13(3):266-72. PubMed ID: 8689849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
